Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes

Recent neuropathological studies have described widespread amyloid-β peptide (Aβ) deposition in the striatum of patients with Lewy body disorders, particularly in Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). However, positron emission tomography (PET) studies usi...

Full description

Bibliographic Details
Main Authors: M.E. Kalaitzakis, A.J. Walls, R.K.B. Pearce, S.M. Gentleman
Format: Article
Language:English
Published: Elsevier 2011-02-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996110003396
_version_ 1818350604325486592
author M.E. Kalaitzakis
A.J. Walls
R.K.B. Pearce
S.M. Gentleman
author_facet M.E. Kalaitzakis
A.J. Walls
R.K.B. Pearce
S.M. Gentleman
author_sort M.E. Kalaitzakis
collection DOAJ
description Recent neuropathological studies have described widespread amyloid-β peptide (Aβ) deposition in the striatum of patients with Lewy body disorders, particularly in Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). However, positron emission tomography (PET) studies using the [11C]PIB ligand, binding to Aβ deposits, detects significant striatal pathology only in DLB and not in PDD. Employing immunohistochemistry, we examined striatal Aβ deposition in the caudate nucleus and putamen of 52 PD, 41 PDD, 14 DLB, 7 multiple system atrophy (MSA) and 14 progressive supranuclear palsy (PSP) cases in relation to the presence of dementia. PD, MSA and PSP cases showed little or no Aβ pathology in the striatum. In contrast, both PDD and DLB cases demonstrated significantly greater Aβ deposition in the striatum when compared to PD, MSA and PSP groups. We conclude that striatal Aβ pathology is common in both PDD and DLB and may reflect the development of dementia in these conditions. More detailed examination of the morphology of the Aβ pathology suggests that it is the presence of cored amyloid plaques in DLB, but not PDD, that underlies the differences seen in PET imaging.
first_indexed 2024-12-13T18:24:29Z
format Article
id doaj.art-60e3a33e5fc74a8698e05d549d1af1fb
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-13T18:24:29Z
publishDate 2011-02-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-60e3a33e5fc74a8698e05d549d1af1fb2022-12-21T23:35:38ZengElsevierNeurobiology of Disease1095-953X2011-02-01412377384Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromesM.E. Kalaitzakis0A.J. Walls1R.K.B. Pearce2S.M. Gentleman3Corresponding author.; Neuropathology Unit, Centre for Neuroscience, Division of Experimental Medicine, Department of Medicine, Imperial College London, Charing Cross Campus, St Dunstan's Road, London, UK, W6 8RPNeuropathology Unit, Centre for Neuroscience, Division of Experimental Medicine, Department of Medicine, Imperial College London, Charing Cross Campus, St Dunstan's Road, London, UK, W6 8RPNeuropathology Unit, Centre for Neuroscience, Division of Experimental Medicine, Department of Medicine, Imperial College London, Charing Cross Campus, St Dunstan's Road, London, UK, W6 8RPNeuropathology Unit, Centre for Neuroscience, Division of Experimental Medicine, Department of Medicine, Imperial College London, Charing Cross Campus, St Dunstan's Road, London, UK, W6 8RPRecent neuropathological studies have described widespread amyloid-β peptide (Aβ) deposition in the striatum of patients with Lewy body disorders, particularly in Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). However, positron emission tomography (PET) studies using the [11C]PIB ligand, binding to Aβ deposits, detects significant striatal pathology only in DLB and not in PDD. Employing immunohistochemistry, we examined striatal Aβ deposition in the caudate nucleus and putamen of 52 PD, 41 PDD, 14 DLB, 7 multiple system atrophy (MSA) and 14 progressive supranuclear palsy (PSP) cases in relation to the presence of dementia. PD, MSA and PSP cases showed little or no Aβ pathology in the striatum. In contrast, both PDD and DLB cases demonstrated significantly greater Aβ deposition in the striatum when compared to PD, MSA and PSP groups. We conclude that striatal Aβ pathology is common in both PDD and DLB and may reflect the development of dementia in these conditions. More detailed examination of the morphology of the Aβ pathology suggests that it is the presence of cored amyloid plaques in DLB, but not PDD, that underlies the differences seen in PET imaging.http://www.sciencedirect.com/science/article/pii/S0969996110003396Parkinson's diseaseDementiaStriatumAmyloid-β peptide[11C]PIB ligandDementia with Lewy bodies
spellingShingle M.E. Kalaitzakis
A.J. Walls
R.K.B. Pearce
S.M. Gentleman
Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
Neurobiology of Disease
Parkinson's disease
Dementia
Striatum
Amyloid-β peptide
[11C]PIB ligand
Dementia with Lewy bodies
title Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
title_full Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
title_fullStr Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
title_full_unstemmed Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
title_short Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
title_sort striatal aβ peptide deposition mirrors dementia and differentiates dlb and pdd from other parkinsonian syndromes
topic Parkinson's disease
Dementia
Striatum
Amyloid-β peptide
[11C]PIB ligand
Dementia with Lewy bodies
url http://www.sciencedirect.com/science/article/pii/S0969996110003396
work_keys_str_mv AT mekalaitzakis striatalabpeptidedepositionmirrorsdementiaanddifferentiatesdlbandpddfromotherparkinsoniansyndromes
AT ajwalls striatalabpeptidedepositionmirrorsdementiaanddifferentiatesdlbandpddfromotherparkinsoniansyndromes
AT rkbpearce striatalabpeptidedepositionmirrorsdementiaanddifferentiatesdlbandpddfromotherparkinsoniansyndromes
AT smgentleman striatalabpeptidedepositionmirrorsdementiaanddifferentiatesdlbandpddfromotherparkinsoniansyndromes